郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors.

期刊：Molecules (Basel, Switzerland)发表年份：2022作者：Kristina Puls; Helmut Schmidhammer; Gerhard Wolber; Mariana Spetea
阅读更多 →

药效评价Synthesis and SAR Studies of Isoquinoline and Tetrahydroisoquinoline Derivatives as Melatonin Receptor Ligands.

期刊：ChemMedChem发表年份：2022作者：Mohamed Ettaoussi; Amélie Laversin; Brandon Vreulz; Marouane Rami; Nicolas Lebegue; Philippe Delagrange; Daniel Henri Caignard; Patricia Melnyk; Maxime Liberelle; Saïd Yous
阅读更多 →

药效评价Hinge influences in murine IgG binding to Cryptococcus neoformans capsule.

期刊：Immunology发表年份：2022作者：Diane Sthefany Lima de Oliveira; Verenice Paredes; Adrielle Veloso Caixeta; Nicole Moreira Henriques; Maggie P Wear; Patrícia Albuquerque; Maria Sueli Soares Felipe; Arturo Casadevall; André Moraes Nicola
阅读更多 →

药效评价The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model.

期刊：Neuropharmacology发表年份：2022作者：Petra Bloms-Funke; Marion Bankstahl; Jens Bankstahl; Christa Kneip; Wolfgang Schröder; Wolfgang Löscher
阅读更多 →